These data suggest that chronic hyperinsulinemia causes both increased M1-type MΦ activation via inducing adipocyte hypertrophy and decreased M2a-subtype MΦ activation via Irs2 downregulation, thereby leading to the development of inflammation and insulin resistance. The gene discussed is IRS2; the disease is Hyperinsulinemia.